usak escort elazig escort

702 / Implementation of safe practices for the administration of potassium chloride

SPAIN
Classification of the PSP
Type of Patient Safety Practice Not Proven Effective
 
Clinical Practice (CP)
Related practices from PaSQ database
"Best fit" category of the reported practice
Medication / IV Fluids
Documentation There is no specified text here
Topic of the reported practice
Patient safety system
Aim and the benefit of the Patient Safety Practice
 
Incorrect intravenous (IV) administration of concentrated Potassium Chloride (KCl) solutions is a lethal risk for hospitalized patients. The Quality Agency for the Spanish National Health System has recommended safe practices to reduce this risk.
Description of the Patient Safety Practice
 
Material and Methods
In May, 2011 the hospital Group for the Safe Use of Medication identified KCl as a risk medication. It decided to implement labeling of diluted KCl solutions by the nursing personnel responsible for preparing and administering them in Cardiology, Cardiac Surgery, Emergency Observation, Coronary Care, Post-Operative Care, Post- Cardiac Care and Intensive Care. Information on the label included patient identification, prescribed KCl dose, volume, and solution type.
A month (22 August - 26 September, 2011) prospective observational study with 10 cross-sectional time points was performed. Two independent observers evaluated adherence to the safe practice.
The adherence index (%) was calculated by dividing the number of patients with labeled KCl solution by the total number of patients prescribed KCl.
Results
Of the total 898 patients hospitalized in these Units during the study, those prescribed KCl included: 14 in Cardiology, 18 in Cardiac Surgery, 34 in Coronary Care, 14 in Emergency Observation, 8 in Post-Operative Care, 32 in Post-Cardiac and 78 in Intensive Care.
The adherence index for labeling of KCl solutions by nursing staff was 100% in all units except Cardiac Surgery (88.8%) and Intensive Care (97.4%).
Conclusions
-Adherence to the labeling initiative of the Group for the Safe use of Medication was very high, almost 100%.
-Safe practices that reduce patient risk increase the quality of health systems and the level of satisfaction among health care professionals.

Attachment of relevant written information and/or photos, as appropriate
655_WP4_Anexo 3 modelo etiquetas ClK.pdf
There is no specified text here
There is no specified text here
There is no specified text here
Effectiveness of the Patient Safety Practice
 
Degree of implementation of reported practice
Yes, fully
Level of implementation of reported practice
Institution level
Specific and measurable outcome for the reported practice were defined
Yes
A baseline measurement before implementation of the reported practice was obtained
Yes
A measurement after full implementation of the reported practice was obtained
Yes
Evaluation of a "positive" effect of the reported practice on Patient Safety
Effect not known or the intervention has not yet been evaluated
Type of before-and after evaluation
Quantitative
Enclosure of a reference or attachment in case of published evaluation's results
Yes, at the EAHP Congress Milan 2012
AM López González1, C Matallana Martín1, MC Izquierdo Navarro1, M Berdón Berdón2, MT Sánchez Sánchez1
1 Hospital Clínico Universitario de Valladolid, Pharmacy Department, Valladolid,
Spain
2 Hospital Clínico Universitario de Valladolid, Nursing Management, Valladolid,
Spain

655_WP4_EN_Etiquetado Cl K 111011[1].doc
Health care context where the Patient Safety Practices was implemented
 
Hospital
Transferability
 
Successful implementation of this Patient Safety Practice in other health care settings than above stated
No
Specification of implementation in another health care setting(s)
There is no specified text here
Successful implementation's level  of this Patient Safety Practice across settings
There is no specified text here
Involved health care staff
 
Nurses
Pharmacists
Patient Involvement
 
Direct service user's involvement as integral part of this Patient Safety Practice
No
Specification of the service users or their representatives' involvement in the implementation of this Patient Safety Practice
There is no specified text here
Point of time in which service user or their reprasentatives' involvement takes place
There is no specified text here
Active seeking of service users' opinion, feedback, experience, etc. as integral part of this Patient Safety Practice
There is no specified text here
Short description of the service users' level of involvement
There is no specified text here
Public accessibility of information regarding this Patient Safety Practice to patients and citizens/service users
No
List of sources where public information is accessible
There is no specified text here
Implementation of the Patient Safety Practice
 
Existing collaboration with other countries or international organisations related to implementation of this Patient Safety Practice
No
Problems encountering in the implememntation course of this Patient Safety Practice like lack of motivation, no management support, etc.
No
List of the most prevelent difficulties encuntered during implementation of this Patient Safety Practice
There is no specified text here
List of the most prevalent drivers for a successful implemetation of this Patient Safety Practice
Motivated staff
Use of any specific incentives to enhance motivation while implementing this Patient Safety Practice
No
Description of used incentives, if any.
There is no specified text here
Existence of support or approval by the clinical or hospital management or any other hihg level authority in the implementation process of this Patient Safety Practice
Not known
Costs of the Patient Safety Practices
 
Completion of cost calculation related to this Patient Safety Practice
No
Total number of person days required to implement this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total number of person days required for training as preparation for implementation of this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total cost in Euro of specific equipment (machines, software, communications supplies, etc.) needed to support implementation of this Patient Safety Practice
There is no specified text here
Associated cost with a work reduction or foregoing in order to deliver this Patient Safety Practice
There is no specified text here
Contact information
 
Name: Ana López
Country: SPAIN
Organisation: Hospital Clínico Universitario de Valladolid, Castile and León
E-mail: analopezfar@gmail.com
Phone: There is no specified text here
Print
Top
instagram takipçi satın al